(2)The approval of the active substance gamma-cyhalothrin expired on 31 March 2025 while the approval of the active substance ipconazole was withdrawn with Commission Implementing Regulation (EU) 2023/939note and the approval of the active substance oxamyl was not renewed with Commission Implementing Regulation (EU) 2023/741note. Therefore, their listing in the Annex to Implementing Regulation (EU) 2015/408 is no longer relevant. In the interest of clarity and transparency, they should be deleted from that Annex.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.